BPAX Short Squeeze Is On


This article is done by Stock Analyzer of Super Nova Alerts

Biosante Pharmaceuticals (NASDAQ:BPAX)

If you enjoy a good short squeeze play then you need to take a look at BPAX which is currently trading at $.66 cents per share which is up nearly 23% today on just under 13 million shares which is the largest volume day in several weeks.

BPAX which is a a specialty pharmaceutical company that develops products for female sexual health and oncology has soared recently as short sellers may finally be feeling the squeeze.


According to ShortSqueeze.com there are nearly 17 million shares short on BPAX currently which represents 16% of the float.

Super Nova alerts sees BPAX as a short term swing trade with a possibility of testing $.75 to $.80 in price with a tight stop loss at $.55.

With iShares Biotechnology index is up over 12 percent over the last month investors are brace for big drug launches and FDA hearings that are soon to come. This may impact BPAX significantly in the near future so check back often for more updates.

 

More Posts by this author


SuperNova
Post Written By: Super Nova

As a trader, I have spent the last 15 years navigating and scanning the penny stock markets. I don’t know anyone who has the breadth and depth of penny stock experience that I do. Through my proven methods I have consistently found some of the markets biggest and most profitable trades…and the great news is that I will share them with all of my subscribers.

Signup for my newsletter at TopStockPicks.com


Ed Liston

Ed Liston is a senior contributing editor at TheStockMarketWatch.com. An active market watcher and investor, Ed guides an independent team of experienced analysts and writes for multiple stock trader publications. He is widely quoted in various financial publications on the Internet. When Ed is not writing about stocks, investing in stocks, talking about stocks, or otherwise doing something stock related, he likes to go sailing and fishing.

You may also like...